0
0
Read Time:7 Second
Johnson & Johnson has agreed to purchase Abiomed, a heart-device maker, for an initial $16.6 billion including cash in the deal.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %